The addressable patient expansion is estimated to grow the anti-obesity medication market by 180 million new prescription patients between 2027 and 2032
Call 800-277-4041 for a Free Consultation What to expect during your consultation:
Be mindful of meal timing
Last reviewed: May 14, 2026 Last updated: May 14, 2026 Last reviewed: May 13, 2026 Last updated: May 13, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
For patients whose clinician prioritizes cardiovascular risk reduction alongside weight loss, this is a meaningful differentiator
Reactions were terminated by washing with ice-cold Krebs buffer